Top of page
Skip to main content
Emory University home
Emory UniversityHealthcare Innovation Program
  • Home
  •  
    Contact Us
  • Home
  • About
  • Program Topics
  • Projects
  • Faculty (current)
  • Resources
  • Educational Offerings
Main content
  1. Healthcare Innovation Program
  2. Faculty and Staff Affiliations
  3. Rathi Pillai, MD

Rathi Pillai, MD


  • Assistant Professor of Hematology & Medical Oncology, Emory University School of Medicine
Email
rnpilla@emory.edu
Phone
(404) 778-5378
View Profile

Sponsored Research Projects

  • A Phase III, Open Label, Randomised, Multi-centre, International Study of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non-Sm
  • A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre, International Study of MEDI4736 as Sequential Therapy in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following De
  • CA209-026: An Open-Label, Randomized Phase 3 Trial of Nivolumab versus Investigator's choice
  • CA209-817: Phase IIIb/IV Trial of Flat Dose Nivolumab w/ Ipilimumab

Program Topics

  • Outcomes and Evaluations

Affiliated Units

  • Emory University School of Medicine
  • Faculty and Staff
  • University Faculty
  • Health Systems Faculty
  • Other Organization Faculty
  • Update Your Information
Back to main contentBack to top
Emory University home
Healthcare Innovation Program logo
FacebookTwitterInstagram
Copyright © Emory University
EO/AA Statement | Copyright
Back to top